Senescence-messaging secretome: SMS-ing cellular stress
The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Abstract
Oncogene-induced cellular senescence constitutes a strong anti-proliferative response, which can be set in motion following either oncogene activation or loss of tumour suppressor signalling. It serves to limit the expansion of early neoplastic cells and as such is a potent cancer-protective response to oncogenic events. Recently emerging evidence points to a crucial role in oncogene-induced cellular senescence for the 'senescence-messaging secretome' or SMS, setting the stage for cross-talk between senescent cells and their environment. How are such signals integrated into a coordinated response and what are the implications of this unexpected finding?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the SASP reinforces and spreads senescence in autocrine and paracrine fashions (Acosta et al., 2013; Coppe ´ et al., 2010; Kuilman and Peeper, 2009) and activates immune responses that eliminate senescent cells (Krizhanovsky et al., 2008a; Mun ˜ oz-Espı ´n and Serrano, 2014).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“Senescent cells secrete a plethora of factors, including pro-inflammatory cytokines and chemokines, growth modulators, angiogenic factors, and matrix metalloproteinases (MMPs), collectively termed the senescent associated secretory phenotype (SASP) or senescence messaging secretome (SMS) (Figure 1; Table 2) (Coppe ´ et al., 2010; Kuilman and Peeper, 2009).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“OIS or senescence induced by loss of a tumor suppressor was verified in vivo in human and murine preneoplastic lesions (Collado et al., 2005; Gorgoulis and Halazonetis, 2010; Kuilman and Peeper, 2009) and primary or treated neoplasias (Haugstetter et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“In most studies, senescence is assessed in ex vivo cultures or fresh samples by SAb -gal staining or indirect markers in formalin-fixed tissues”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“This SASP or senescence messaging secretome (SMS) (Kuilman and Peeper 2009) reflects the non-cell-autonomous functionality of senescent cells and may underpin their in vivo role in the pathophysiology of aging and age-related disorders.”
From Cellular senescence and its effector programs (2014) · cites this paper as Kuilman and Peeper 2009
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“OIS corresponds to a premature form of cellular senescenc”
BackgroundCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“For instance, in a mouse model of liver carcinoma driven by inducible shRNA-mediated depletion of p53 and HRAS V12 expression, Scott Lowe's laboratory showed that reactivation of p53 in the tumour results in a robust senescence respons”
BackgroundSenescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“OIS and replicative senescence share a number of characteristics, including an increase in senescence-associated β-galactosidase (SA-β-GAL) activity and the condensation of individual chromosomes into distinct heterochromatic bodies, called senescence-associated heterochromatic foci (SAHF”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Self-citationSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Pleiotropy, natural selection, and the evolution of senescence
Williams, G. C. (1957) · Evolution · doi:10.2307/2406060 · Cited by 1,912
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801 · cited 1×
“Consequently, we came to realize that, in fact, in addition to the aforementioned factors, numerous inflammatory proteins and mediators of ECM remodelling are strongly induced in senescent cell”
BackgroundKirkwood, T. B. L., & Austad, S. N. (2000) · Nature · doi:10.1038/35041682 · Cited by 1,774
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,750
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Making sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · cited 1×
“Despite the existence of these functional connections, it is as yet unclear to what extent these in vitro findings, and also the dominant role of Wnt signalling in tumorigenesi”
BackgroundSenescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482 · cited 1×
“Although this was tested in another context, chemically induced papillomas indeed express several senescence marker”
BackgroundOncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Living on a break: cellular senescence as a DNA-damage response
d'Adda di Fagagna, F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2440 · Cited by 1,170
Cellular Senescence in Aging Primates
Herbig, U., Ferreira, M., Condel, L., Carey, D., & Sedivy, J. M. (2006) · Science · doi:10.1126/science.1122446 · Cited by 1,101 · cited 1×
“This could become relevant in the case of large benign, senescent tumours, or in the case of ageing, in which senescent cells accumulat”
BackgroundMannose 6-phosphate receptors: new twists in the tale
Ghosh, P., Dahms, N. M., & Kornfeld, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1050 · Cited by 1,086
Rotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062 · cited 1×
“122 ), the latter inhibits phosphorylation of IRS1 in primary murine hepatocytes and hepatocellular carcinom”
BackgroundThe signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046 · cited 1×
“Their crucial roles in senescence are highlighted by their almost invariable inactivation in cance”
BackgroundThe common biology of cancer and ageing
Finkel, T., Serrano, M., & Blasco, M. A. (2007) · Nature · doi:10.1038/nature05985 · Cited by 988 · cited 1×
“Furthermore, senescence may have important implications for agein”
BackgroundSato, Y., & Rifkin, D. B. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.1.309 · Cited by 905
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903 · cited 1×
“, was identified in an RNA interference screen for crucial mediators of BRAF E600 -induced senescence in human diploid fibroblasts (HDFs) and melanocyte”
BackgroundInterleukin-6 induces cellular insulin resistance in hepatocytes.
Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3391 · Cited by 883 · cited 1×
“122 ), the latter inhibits phosphorylation of IRS1 in primary murine hepatocytes and hepatocellular carcinom”
BackgroundRas-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
Augmented Wnt signaling in a mammalian model of accelerated aging
Liu, H., Fergusson, M. M., Castilho, R. M., Liu, J., Cao, L., Chen, J., Malide, D., Rovira, I. I., Schimel, D., Kuo, C. J., et al. (2007) · Science · doi:10.1126/science.1143578 · Cited by 755 · cited 1×
“shows the opposite in both human and murine fibroblast cells: WNT3A caused these cells to enter senescence prematurel”
BackgroundZhang, R., Poustovoitov, M. V., Ye, X., Santos, H. A., Chen, W., Daganzo, S. M., Erzberger, J. P., Serebriiskii, I. G., Canutescu, A. A., Dunbrack, R. L., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2004.10.019 · Cited by 699
Interleukin-6 and its receptor: a paradigm for cytokines
Kishimoto, T., Akira, S., & Taga, T. (1992) · Science · doi:10.1126/science.1411569 · Cited by 665
Kortlever, R. M., Higgins, P. J., & Bernards, R. (2006) · Nature Cell Biology · doi:10.1038/ncb1448 · Cited by 637 · cited 1×
“demonstrated that it does have a fundamental role in replicative senescenc”
BackgroundMiyazono, K., Hellman, U., Wernstedt, C., & Heldin, C. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68800-3 · Cited by 637
A novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation
Narita, M., Narita, M., Krizhanovsky, V., Nuñez, S., Chicas, A., Hearn, S. A., Myers, M. P., & Lowe, S. W. (2006) · Cell · doi:10.1016/j.cell.2006.05.052 · Cited by 629
Wakefield, L. M., Smith, D. M., Flanders, K. C., & Sporn, M. B. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68547-3 · Cited by 538
Dennis, P. A., & Rifkin, D. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.580 · Cited by 516
A negative feedback signaling network underlies oncogene-induced senescence
Courtois-Cox, S., Genther Williams, S. M., Reczek, E. E., Johnson, B. W., McGillicuddy, L. T., Johannessen, C. M., Hollstein, P. E., MacCollin, M., & Cichowski, K. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.003 · Cited by 501 · cited 1×
“Feedback inhibition of growth factor signalling has been previously proposed to have a causal role in the activation of senescence, in the context of loss of the neurofibromatosis tumour suppressor, NF1 (Ref”
BackgroundHerz, J., Clouthier, D. E., & Hammer, R. E. (1992) · Cell · doi:10.1016/0092-8674(92)90511-a · Cited by 497
Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491
Delayed ageing through damage protection by the Arf/p53 pathway
Matheu, A., Maraver, A., Klatt, P., Flores, I., Garcia-Cao, I., Borras, C., Flores, J. M., Viña, J., Blasco, M. A., & Serrano, M. (2007) · Nature · doi:10.1038/nature05949 · Cited by 466 · cited 1×
“However, somewhat counterintuitively, mice carrying an extra copy of either Arf or Trp53 (both of which are implicated in senescence) display an increased lifespa”
BackgroundNykjaer, A., Petersen, C. M., Møller, B., Jensen, P. H., Moestrup, S. K., Holtet, T. L., Etzerodt, M., Thøgersen, H. C., Munch, M., & Andreasen, P. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42072-8 · Cited by 459
Lewis, A. M., Varghese, S., Xu, H., & Alexander, H. R. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-48 · Cited by 443
Evolving role of uPA/uPAR system in human cancers
Dass, K., Ahmad, A., Azmi, A. S., Sarkar, S. H., & Sarkar, F. H. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.10.005 · Cited by 423
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis
Ancrile, B., Lim, K.-H., & Counter, C. M. (2007) · Genes & Development · doi:10.1101/gad.1549407 · Cited by 422
Telomere dysfunction and tumour suppression: the senescence connection
Deng, Y., Chan, S. S., & Chang, S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2393 · Cited by 411
The power and the promise of oncogene-induced senescence markers
Collado, M., & Serrano, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1884 · Cited by 404 · cited 1×
“PAI1 has long been regarded as a marker that merely correlates with, rather than contributes to, senescenc”
BackgroundExtension of the Life-Span of Human Endothelial Cells by an Interleukin-1αAntisense Oligomer
Maier, J. A. M., Voulalas, P., Roeder, D., & Maciag, T. (1990) · Science · doi:10.1126/science.2218499 · Cited by 397
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
Gray-Schopfer, V. C., Cheong, S. C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z. A., Marais, R., Wynford-Thomas, D., & Bennett, D. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603283 · Cited by 394
Brown, R. A., Prajapati, R., McGrouther, D. A., Yannas, I. V., & Eastwood, M. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199806)175:3<323::aid-jcp10>3.0.co;2-6 · Cited by 388
Oncogene-Induced Cell Senescence — Halting on the Road to Cancer
Mooi, W. J., & Peeper, D. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062285 · Cited by 371
Self-citationInterleukin‐6 and its receptor in cancer: Implications for Translational Therapeutics
Hong, D. S., Angelo, L. S., & Kurzrock, R. (2007) · Cancer · doi:10.1002/cncr.22999 · Cited by 370
A Single Receptor Binds Both Insulin-Like Growth Factor II and Mannose-6-Phosphate
MacDonald, R. G., Pfeffer, S. R., Coussens, L., Tepper, M. A., Brocklebank, C. M., Mole, J. E., Anderson, J. K., Chen, E., Czech, M. P., & Ullrich, A. (1988) · Science · doi:10.1126/science.2964083 · Cited by 370
Endocrine regulation of ageing
Russell, S. J., & Kahn, C. R. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2234 · Cited by 356
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
De Souza, A. T., Hankins, G. R., Washington, M. K., Orton, T. C., & Jirtle, R. L. (1995) · Nature Genetics · doi:10.1038/ng1295-447 · Cited by 355
Denoyelle, C., Abou-Rjaily, G., Bezrookove, V., Verhaegen, M., Johnson, T. M., Fullen, D. R., Pointer, J. N., Gruber, S. B., Su, L. D., Nikiforov, M. A., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1471 · Cited by 349 · cited 1×
“However, a decrease in active Erk in the context of BRAF E600 -induced senescence is in apparent contrast to earlier reports, in which expression of BRAF E600 induced activation of ERK1 (MAPK3) and ERK2 (Ref”
ResultYang, G., Rosen, D. G., Zhang, Z., Bast, R. C., Mills, G. B., Colacino, J. A., Mercado-Uribe, I., & Liu, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605752103 · Cited by 341
Frippiat, C., Chen, Q. M., Zdanov, S., Magalhaes, J.-P., Remacle, J., & Toussaint, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006809200 · Cited by 316
Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas
Paradis, V., Youssef, N., Dargère, D., Bâ, N., Bonvoust, F., Deschatrette, J., & Bedossa, P. (2001) · Human Pathology · doi:10.1053/hupa.2001.22747 · Cited by 314
Short Telomeres Limit Tumor Progression In Vivo by Inducing Senescence
Feldser, D. M., & Greider, C. W. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.026 · Cited by 314
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
Nykjar, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2610 · Cited by 309
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 1×
“Also in the setting of replicative senescence, p53 is not necessary for the concomitant induction of IL-6 and other secreted factor”
BackgroundCancer and aging: a model for the cancer promoting effects of the aging stroma
Krtolica, A., & Campisi, J. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00053-5 · Cited by 295
BRAFE600 in benign and malignant human tumours
Michaloglou, C., Vredeveld, L. C. W., Mooi, W. J., & Peeper, D. S. (2008) · Oncogene · doi:10.1038/sj.onc.1210704 · Cited by 275
Self-citationDebacq-Chainiaux, F., Borlon, C., Pascal, T., Royer, V., Eliaers, F., Ninane, N., Carrard, G., Friguet, B., de Longueville, F., Boffe, S., et al. (2005) · Journal of Cell Science · doi:10.1242/jcs.01651 · Cited by 263
Cellular senescence in vivo: a barrier to tumorigenesis
Prieur, A., & Peeper, D. S. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.007 · Cited by 260
Self-citationLeal, S. M., Liu, Q., Huang, S. S., & Huang, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20572 · Cited by 255
Gucev, Z. S., Oh, Y., Kelley, K. M., & Rosenfeld, R. G. (1996) · PubMed · Cited by 253
DNA Damage Signaling and p53-dependent Senescence after Prolonged β-Interferon Stimulation
Moiseeva, O., Mallette, F. A., Mukhopadhyay, U. K., Moores, A., & Ferbeyre, G. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-09-0858 · Cited by 252
The role of interleukin-8 in cancer cells and microenvironment interaction
Yuan, A. (2005) · Frontiers in Bioscience · doi:10.2741/1579 · Cited by 252
Role of insulin-like growth factor 1 receptor signalling in cancer
Larsson, O., Girnita, A., & Girnita, L. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602627 · Cited by 246
Orth, K., Madison, E. L., Gething, M. J., Sambrook, J. F., & Herz, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7422 · Cited by 244
Chakravarthy, M. V., Abraha, T. W., Schwartz, R. J., Fiorotto, M. L., & Booth, F. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005832200 · Cited by 239
Breese, C. R., Ingram, R. L., & Sonntag, W. E. (1991) · Journal of Gerontology · doi:10.1093/geronj/46.5.b180 · Cited by 236
Ye, X., Zerlanko, B., Kennedy, A., Banumathy, G., Zhang, R., & Adams, P. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.034 · Cited by 228
Human melanocyte senescence and melanoma susceptibility genes
Bennett, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206446 · Cited by 212
Purchio, A. F., Cooper, J. A., Brunner, A. M., Lioubin, M. N., Gentry, L. E., Kovacina, K. S., Roth, R. A., & Marquardt, H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68207-9 · Cited by 207
Damalas, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4912 · Cited by 207
Cosme‐Blanco, W., Shen, M., Lazar, A. J. F., Pathak, S., Lozano, G., Multani, A. S., & Chang, S. (2007) · The EMBO Reports · doi:10.1038/sj.embor.7400937 · Cited by 205 · cited 1×
“Several mechanisms, including telomere shortening, have been proposed to mechanistically explain thi”
BackgroundKim, K. S., Seu, Y. B., Baek, S.-H., Kim, M. J., Kim, K. J., Kim, J. H., & Kim, J.-R. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-03-0280 · Cited by 199 · cited 1×
“Treatment of HUVECs with recombinant IGFBP3 or IGFBP5 is sufficient to slow down proliferation and provoke markers of senescenc”
BackgroundConese, M., Nykjaer, A., Petersen, C. M., Cremona, O., Pardi, R., Andreasen, P. A., Gliemann, J., Christensen, E. I., & Blasi, F. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.6.1609 · Cited by 191
Olson, D., Pöllänen, J., Høyer-Hansen, G., Rønne, E., Sakaguchi, K., Wun, T. C., Appella, E., Danø, K., & Blasi, F. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50398-2 · Cited by 184
Godár, S., Hořejší, V., Weidle, U. H., Binder, B. R., Hansmann, C., & Stockinger, H. S. J. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199903)29:03<1004::aid-immu1004>3.0.co;2-q · Cited by 182
Adams, P. D. (2007) · Gene · doi:10.1016/j.gene.2007.04.020 · Cited by 176
Lu, C., Vickers, M. F., & Kerbel, R. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9215 · Cited by 170
Ye, X., Zerlanko, B., Zhang, R., Somaiah, N., Lipinski, M., Salomoni, P., & Adams, P. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01592-06 · Cited by 162
Cellular growth inhibition by IGFBP‐3 and TGF‐β 1 requires LRP‐1
Huang, S. S., Ling, T.-Y., Tseng, W.-F., Huang, Y.-H., Tang, F.-M., Leal, S. M., & Huang, J. S. (2003) · The FASEB Journal · doi:10.1096/fj.03-0256com · Cited by 157
Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.
Glick, A. B., Lee, M. M., Darwiche, N., Kulkarni, A. B., Karlsson, S., & Yuspa, S. H. (1994) · Genes & Development · doi:10.1101/gad.8.20.2429 · Cited by 157
Epigenetic silencing of multiple interferon pathway genes after cellular immortalization
Kulaeva, O. I., Drăghici, S., Tang, L., Kraniak, J. M., Land, S. J., & Tainsky, M. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206594 · Cited by 154
Latent high molecular weight complex of transforming growth factor. beta. 1
Miyazono, K., Hellman, U., Wernstedt, C., & Heldin, C. H. (1988) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 146
Kunz, C., Pebler, S., Otte, J., & von der Ahe, D. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.18.3710 · Cited by 144
Weigert, C., Hennige, A. M., Lehmann, R., Brodbeck, K., Baumgartner, F., Schaüble, M., Häring, H. U., & Schleicher, E. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509782200 · Cited by 141
Nykjær, A., Christensen, E. I., Vorum, H., Hager, H., Petersen, C. M., Røigaard, H., Min, H. Y., Vilhardt, F., Møller, L. B., Kornfeld, S., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.3.815 · Cited by 141
Massagué, J., Kelly, B., & Mottola, C. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89102-5 · Cited by 134
Hanafusa, T., Yumoto, Y., Nouso, K., Nakatsukasa, H., Onishi, T., Fujikawa, T., 谷山真由美, Nakamura, S., Uemura, M., Takuma, Y., et al. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00736-4 · Cited by 126
Kovacina, K. S., Steele-Perkins, G., Purchio, A. F., Lioubin, M., Miyazono, K., Heldin, C.-H., & Roth, R. A. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91669-0 · Cited by 126
Carrieri, G., Marzi, E., Olivieri, F., Marchegiani, F., Cavallone, L., Cardelli, M., Giovagnetti, S., Stecconi, R., Molendini, C., Trapassi, C., et al. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00129.x · Cited by 125
Andreozzi, F., Laratta, E., Procopio, M. C., Hribal, M. L., Sciacqua, A., Perticone, M., Miele, C., Perticone, F., & Sesti, G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01340-06 · Cited by 123
Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.
Vijayachandra, K., Lee, J., & Glick, A. B. (2003) · PubMed · Cited by 113
Fanayan, S., Firth, S. M., Butt, A. J., & Baxter, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006964200 · Cited by 112
Defects in TGFβ signaling overcome senescence of mouse keratinocytes expressing v-rasHa
Tremain, R., Marko, M. G., Vijayachandra, K., Ueno, H., Böttinger, E. P., & Glick, A. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203471 · Cited by 112
Goldstein, S., Moerman, E. J., Jones, R. A., & Baxter, R. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9680 · Cited by 104
Leal, S. M., Huang, S. S., & Huang, J. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6711 · Cited by 104
Developmental response to hypoxia
Huang, S. ‐. J., Vo, K. C. T., Lyell, D. J., Faessen, G. H., Tulac, S., Tibshirani, R., Giaccia, A. J., & Giudice, L. C. (2004) · The FASEB Journal · doi:10.1096/fj.03-1377com · Cited by 104
Fanayan, S., Firth, S. M., & Baxter, R. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108038200 · Cited by 103
Wilson, H.-M. P., Birnbaum, R. S., Poot, M., Quinn, L. S., & Swisshelm, K. L. (2002) · PubMed · Cited by 94
Oncogenic Ras-Induced Expression of Cytokines: A New Target of Anti-Cancer Therapeutics
Ancrile, B. B., O'Hayer, K. M., & Counter, C. M. (2008) · Molecular Interventions · doi:10.1124/mi.8.1.6 · Cited by 92
Lalou, C., Silve, C., Rosato, R., Segovia, B., & Binoux, M. (1994) · Endocrinology · doi:10.1210/endo.135.6.7527330 · Cited by 91
Hernandez, L. F., Kozlov, S., Piras, G., & Stewart, C. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234026100 · Cited by 91
Sasaki, M., Ikeda, H., Sato, Y., & Nakanuma, Y. (2008) · Free Radical Research · doi:10.1080/10715760802244768 · Cited by 90
Kim, K. S., Kim, M., Seu, Y. B., Chung, H. Y., Kim, J. H., & Kim, J. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00315.x · Cited by 89
Senescence, Wound Healing, and Cancer: the PAI-1 Connection
Kortlever, R. M., & Bernards, R. (2006) · Cell Cycle · doi:10.4161/cc.5.23.3510 · Cited by 84
Role of IFI 16 in cellular senescence of human fibroblasts
Xin, H., Pereira‐Smith, O. M., & Choubey, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207836 · Cited by 81
Insulin-Like Growth Factor Binding Protein-5 Binds to Plasminogen Activator Inhibitor-I
Nam, T. J. (1997) · Endocrinology · doi:10.1210/en.138.7.2972 · Cited by 80
Sprenger, C. C. T., Vail, M. E., Evans, K., Simurdak, J., & Plymate, S. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205021 · Cited by 80
Failure of senescent human fibroblasts to express the insulin-like growth factor-1 gene.
Ferber, A., Chang, C., Sell, C., Ptasznik, A., Cristofalo, V. J., Hubbard, K., Ozer, H. L., Adamo, M., Roberts, C. T., & LeRoith, D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46787-1 · Cited by 79
Aberrant promoter methylation of insulin‐like growth factor binding protein‐3 gene in human cancers
Tomii, K., Tsukuda, K., Toyooka, S., Dote, H., Hanafusa, T., Asano, H., Naitou, M., Doihara, H., Kisimoto, T., Katayama, H., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22341 · Cited by 72
Nolan, C. M., Kyle, J. W., Watanabe, H., & Sly, W. S. (1990) · Cell Regulation · doi:10.1091/mbc.1.2.197 · Cited by 70
Low density lipoprotein receptor-related protein: regulation of the plasma membrane proteome
Wu, L., Salicioni, A., & Gonias, S. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-01-0023 · Cited by 70
TGF-β-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen
Leksa, V., Godár, S., Schiller, H. B., Fuertbauer, E., Muhammad, A., Slezáková, K., Hořejší, V., Steinlein, P., Weidle, U. H., Binder, B. R., et al. (2005) · Journal of Cell Science · doi:10.1242/jcs.02587 · Cited by 70
Molecular markers of senescence in fibroblast-like cultures
Cristofalo, V. J., & Pignolo, R. J. (1996) · Experimental Gerontology · doi:10.1016/0531-5565(95)02018-7 · Cited by 67
Li, Q., Tang, L., Roberts, P. C., Kraniak, J. M., Fridman, A. L., Kulaeva, O. I., Tehrani, O. S., & Tainsky, M. A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0114 · Cited by 63
Goldstein, S., Moerman, E. J., Fujii, S., & Sobel, B. E. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041610321 · Cited by 59
Lü, C., Sheehan, C., Rak, J. W., Chambers, C. A., Hozumi, N., & Kerbel, R. S. (1996) · PubMed · Cited by 58
Kortlever, R. M., Nijwening, J. H., & Bernards, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803341200 · Cited by 54
Fu, V. X., Schwarze, S. R., Kenowski, M. L., LeBlanc, S., Svaren, J., & Jarrard, D. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405015200 · Cited by 51
Hung, P., Kao, S. Y., Shih, Y., Chiou, S., Liu, C., Chang, K., & Lin, S. (2007) · The Journal of Pathology · doi:10.1002/path.2280 · Cited by 49
Pammer, J., Reinisch, C., Birner, P., Pogoda, K., Stürzl, M., & Tschachler, E. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700461 · Cited by 46
The Blockade of IL-6 Signaling in Rational Drug Design
Adachi, Y., Yoshio‐Hoshino, N., & Nishimoto, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784246072 · Cited by 40
Shian Huang, S., M. Leal, S., Chen, C.-L., Liu, I.-H., & San Huang, J. (2004) · The FASEB Journal · doi:10.1096/fj.04-1872fje · Cited by 37
Genes for Insulin-Like Growth Factors I and II Are Expressed in Senescent Rat Tissues
Park, G. H., & Buetow, D. E. (1991) · Gerontology · doi:10.1159/000213278 · Cited by 36
Campbell, P. G., & Andress, D. L. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.5.e996 · Cited by 36
Fridman, A. L., Tang, L., Kulaeva, O. I., Ye, B., Li, Q., Nahhas, F. A., Roberts, P. C., Land, S. J., Abrams, J., & Tainsky, M. A. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.9.879 · Cited by 32
Interferon regulatory factor 3 activates p53-dependent cell growth inhibition
Kim, T.-K., Lee, J.-S., Jung, J.-E., Oh, S.-Y., Kwak, S., Jin, X., Lee, S.-Y., Lee, J.-B., Chung, Y. G., Choi, Y. K., et al. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.003 · Cited by 32
Liu, S., Fang, X., Hall, H. S., Yu, S., Smith, D. L., Lu, Z., Fang, D., Liu, J., Stephens, L. C., Woodgett, J. R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704242105 · Cited by 23
Mück, C., Mičutková, L., Zwerschke, W., & Jansen‐Dürr, P. (2008) · Rejuvenation Research · doi:10.1089/rej.2007.0628 · Cited by 21
Interferon-α repressed telomerase along with G1-accumulation of Daudi cells
Akiyama, M., Iwase, S., Horiguchi‐Yamada, J., Saito, S., Furukawa, Y., Yamada, O., Mizoguchi, H., Ohno, T., & Yamada, H. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00109-3 · Cited by 21
Perera, R. J., Koo, S., Bennett, C. F., Dean, N. M., Gupta, N., Qin, J., & Nickoloff, B. J. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20785 · Cited by 20
Gilardoni, M. B., Ceschin, D. G., Sahores, M. M., Oviedo, M., Gehrau, R. C., & Chiabrando, G. A. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305101201 · Cited by 18
Cellular growth inhibition by TGF-$beta;1 involves IRS proteins*1
Huang, S. S., Leal, S. M., Chen, C., Liu, I., & Huang, J. S. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.082 · Cited by 17
Influence of age on the production of interleukin-8-like chemokine (GRO/CINC-1) in rat nasal mucosa
Himi, T., Yoshioka, I., & Kataura, A. (1997) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/bf01526189 · Cited by 12
Duplomb, L., Chaigne-Delalande, B., Vusio, P., Raher, S., Jacques, Y., Godard, A., & Blanchard, F. (2003) · Endocrinology · doi:10.1210/en.2003-0607 · Cited by 12
Hsu, J.-Y., Hsu, M., Sorger, T., Herlyn, M., & Levine, E. M. (1999) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-999-0105-6 · Cited by 11
TGF-β1 modulation of IGF-I signaling pathway in rat thyroid epithelial cells
Mincione, G. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00155-1 · Cited by 9
Research works printed but not linked: 1
- Gagnon, A. M., Chabot, J., Pardasani, D. & Sorisky, A. Extracellular matrix induced by TGFβ impairs insulin signal transduction in 3T3-L1 preadipose cells. J. Cell Physiol. 175, 370–378 (1998). · doi:10.1002/(sici)1097-4652(199806)175:3<370::aid-jcp15>3.0.co;2-9
Cited by
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
“This phenotype has also been termed the senescence-messaging secretome (35).”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278
Metadata
- Authors
- Kuilman, T., & Peeper, D. S.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Corresponding author
- Peeper, Daniel S.
- Venue
- Nature Reviews Cancer
- Published
- 2009-01-09
- Volume
- 9
- Issue
- 2
- Pages
- 81-94
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2005248738
- Cited by
- 909
- References
- 146
- Citations by year
- 2026: 25 · 2025: 46 · 2024: 46 · 2023: 48 · 2022: 54 · 2021: 73 · 2020: 62 · 2019: 43 · 2018: 63 · 2017: 56 · 2016: 60 · 2015: 53 · 2014: 68 · 2013: 55 · 2012: 47
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- KWF Kankerbestrijding
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- secreted factors, senescence-associated secretory phenotype, cancer protection
- MeSH terms
- Animals, Cell Communication, Humans, Neoplasms, Signal Transduction, Cellular Senescence, Tumor Suppressor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.